Patents by Inventor Claus Peter Kiessling

Claus Peter Kiessling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220144941
    Abstract: The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment.
    Type: Application
    Filed: October 16, 2019
    Publication date: May 12, 2022
    Inventors: Melissa Kaye Brock, William James Byrnes, Bernhard Heinrich Greve, Claus Peter Kiessling, Grant Langdon, Elizabeth Webster Manis
  • Publication number: 20200140548
    Abstract: The disclosure relates to a method of treating or preventing immune (idiopathic) thrombocytopenic purpura (ITP) in a human in need thereof, the method comprising administering to the human in the range of 1 to 5 doses of an anti-FcRn antibody or antigen binding fragment thereof over a treatment period of 1 to 12 weeks, wherein the aggregate dose in the treatment period is in the range of 1 to 30 mg per kg.
    Type: Application
    Filed: June 15, 2018
    Publication date: May 7, 2020
    Inventors: Rocio Lledo-Garcia, Grant Langdon, Claus Peter Kiessling, Rose Gunter Snipes, Ute Massow